Catalera BioSolutions, a Vancouver, BC, Canada-based company which specializes in biological pest control solutions, held the first close of its Series A funding.
Launched mid-May, Catalera is an independent company spun out from Terramera, an ag-tech company based in Vancouver.
The launch of the company is made possible through a US$8M investment round led by S2G Ventures, with participation from Farm Credit Canada (FCC) Capital, and a second and final close expected in Q4 of 2024.
Led by CEO Matthew Dahabieh, Catalera creates biological products using a toolkit of patented technologies to overcome the core challenges that have so far prevented the broad based adoption of biological products. Building on a solid foundation from existing commercial products including: RANGO® for specialty crops, SOCORO® for row crops, Vaporpad® for professional bed bug treatment and the recent registration of TRIFECTO® in Mexico, the company is well positioned to deploy new biological products over the next few years and substantially grow its portfolio.
FinSMEs
10/09/2024